The Italian START-Register on anticoagulation with focus on atrial fibrillation

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Antonucci, Emilia ^a   Poli, Daniela ^b,i   Tosetto, Alberto ^c,i   Pengo, Vittorio ^d,i   Tripodi, Armando ^e,i   Magrini, Nicola ^f,i   Marongiu, Francesco ^g,i   Palareti, Gualtiero ^h,i   Testa, Sophie ⁱ   Paoletti, Oriana ⁱ   Falanga, Anna ⁱ   Lerede, Teresa ⁱ   Guazzaloca, Giuliana ⁱ   Marcucci, Rossella ⁱ   Piana, Antonietta ⁱ   Cibecchini, Francesco ⁱ   Ruocco, Lucia ⁱ   Lucarelli, Giacomo ⁱ   Paparo, Carmelo ⁱ   Martini, Giuliana ⁱ   Scovoli, Giovanni ⁱ   Bradamante, Salvatore ⁱ   Malcangi, Giuseppe ⁱ   Lombardi, Maria ⁱ   Insana, Antonio ⁱ   Toma, Andrea ⁱ   Barbera, Pietro ⁱ   Masciocco, Lucilla ⁱ   Saracino, Pasquale ⁱ   Benvenuto, Angelo ⁱ   Vasselli, Claudio ⁱ   Sangiorgio, Rosella ⁱ   Crippa, Luciano ⁱ   Pedrini, Simona ⁱ   Bertola, Federica ⁱ   Rupoli, Serena ⁱ   Lione, Domenico ⁱ   Pasca, Samantha ⁱ   Roldan, Vanessa ⁱ   Rossi, Vincenza ⁱ   Bucherini, Eugenio ⁱ   Gresele, Paolo ⁱ   Mangione, Catello ⁱ   Cicconi, Silvana ⁱ   Casasco, Paola ⁱ   Castaman, Giancarlo ⁱ   Liberato, Nicola Lucio ⁱ   Bendotti, Cesarina ⁱ   Oriana, Vincenzo ⁱ   Manotti, Paolo ⁱ   Zighetti, Maddalena Loredana ⁱ   Pedico, Paolo ⁱ   Fidone, Enzo ⁱ   Lombardo, Carla ⁱ   Paci, Ornella Onorina ⁱ   Pezzella, Simona ⁱ   Pezzo, Mario ⁱ   Ciampa, Antonio ⁱ   Maccaroni, Italiano ⁱ   Molini, Gabriella ⁱ   Ciardiello, Aurora ⁱ   Marietta, Marco ⁱ   Turrini, Anna ⁱ   Barcellona, Doris ⁱ   more..

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f Agency for Health Care and Social Services of Emilia Romagna   (Italy)

^g DEPARTMENT OF RADIOLOGY   (Italy)

^h Monitor of the START Register   (Italy)

ⁱ NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CREATININE; DABIGATRAN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DRUG INDICATION; FEMALE; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON VALVULAR ATRIAL FIBRILLATION; RISK FACTOR; VENOUS THROMBOEMBOLISM; CHEMICALLY INDUCED; CLINICAL TRIAL; COHORT ANALYSIS; ITALY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; REGISTER; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; COHORT STUDIES; CREATININE; FEMALE; HEMORRHAGE; HUMANS; ITALY; MALE; MIDDLE AGED; REGISTRIES; RENAL INSUFFICIENCY; RISK FACTORS; STROKE;

EID: 84930667892     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124719     Document Type: Article

References (23)

1. th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141: e44S-88S. doi: 10.1378/chest.11-2292 PMID: 22315269
2. Nieuwlaat R, Prins MH, Le Heuzey JY, Vardas PE, Aliot E, Santini M, et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J. 2008; 29: 1181-1189. doi: 10.1093/eurheartj/ehn139 PMID: 18397874
3. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361: 1139-1151. doi: 10.1056/NEJMoa0905561 PMID: 19717844
4. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011; 365: 883-891. doi: 10.1056/NEJMoa1009638 PMID: 21830957
5. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011; 365: 981-992. doi: 10.1056/NEJMoa1107039 PMID: 21870978
6. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013 369: 2093-2104. doi: 10.1056/NEJMoa1310907 PMID: 24251359
7. Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009; 361: 2342-2352. doi: 10.1056/NEJMoa0906598 PMID: 19966341
8. Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Lensing AW, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010; 363: 2499-2510. doi: 10.1056/NEJMoa1007903 PMID: 21128814
9. Buller HR, Prins MH, Lensing AW, Decousus H, Jacobson BF, Minar E, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012; 366: 1287-1297. doi: 10.1056/NEJMoa1113572 PMID: 22449293
10. Buller HR, Decousus H, Grosso MA, Middeldorp S, Prins MH, Raskob GE, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013; 369: 1406-1415. doi: 10.1056/NEJMoa1306638 PMID: 23991658
11. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013; 369: 799-808. doi: 10.1056/NEJMoa1302507 PMID: 23808982
12. Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, et al. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med. 2013; 368: 709-718. doi: 10.1056/NEJMoa1113697 PMID: 23425163
13. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M et al. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013; 368: 699-708. doi: 10.1056/NEJMoa1207541 PMID: 23216615
14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16: 31-41. PMID: 1244564
15. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266 PMID: 11904577
16. Gage BF, vanWalraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, et al. Selecting patients with atrial fibrillation for anticoagulation-Stroke risk stratification in patients taking aspirin. Circulation. 2004; 110: 2287-2292. PMID: 15477396
17. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010; 137: 263-272. doi: 10.1378/chest.09-1584 PMID: 19762550
18. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010; 138: 1093-1100. doi: 10.1378/chest.10-0134 PMID: 20299623
19. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993; 69: 236-239. PMID: 8470047
20. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005; 3: 692-694 PMID: 15842354
21. Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, et al. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One. 2013; 8: e63479. doi: 10.1371/journal.pone.0063479 PMID: 23704912
22. Volterrani M, Iellamo F, Rosano G, Guarini P, Pusineri E, Bonassi S, et al SICOA (Società Italiana Cardiologia Ospedalità Accreditata) Investigators. Anticoagulation in "real world" patients with atrial fibrillation in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study. Int J Cardiol. 2013; 168:4729-4733 doi: 10.1016/j.ijcard.2013.07.169 PMID: 23948115
23. Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey JY, Schilling RJ, et al. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events-European Registry in Atrial Fibrillation (PREFER in AF). Europace. 2014; 16:6-14. doi: 10.1093/europace/eut263 PMID: 24084680